Acumen Pharmaceuticals, Inc. Insider Trading
ABOS
Insiders sold 626K and bought nothing on the open market.
86% of the selling was scheduled in advance under 10b5-1 plans. Director Derrell Porter sold 75K on Jun 17, 48% of their stake, outside a plan. The last open-market buy by an executive or director was in Jul 2021.
Get an email when ABOS's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Jun 15 – 17 | Derrell Porter Director | SoldNo plan 3 parts | 32,300 | $2.33 average | 75K | 48% | Form 4 |
| Jun 9 | Nathan B Fountain Director | SoldNo plan | 6,400 | $2.23 | 14K | 12% | Form 4 |
| Mar 6 | Derek M Meisner Chief Legal Officer & Corp Sec | Sold10b5-1 plan | 2,090 | $3.26 | 7K | 1.2% | Form 4 |
| Feb 27 | Derek M Meisner Chief Legal Officer & Corp Sec | Sold10b5-1 plan | 9,406 | $3.01 | 28K | 5.1% | Form 4 |
| Jan 26 – 28 | Derek M Meisner Chief Legal Officer & Corp Sec | Sold10b5-1 plan 2 parts | 17,756 | $3.00 average | 53K | 9.3% | Form 4 |
| Jan 21 – 23 | Derek M Meisner Chief Legal Officer & Corp Sec | Sold10b5-1 plan 3 parts | 8,934 | $1.87 average | 17K | 4.9% | Form 4 |
| Jan 21 – 22 | Eric Siemers Chief Medical Officer | Sold10b5-1 plan 2 parts | 3,226 | $1.81 average | 6K | 1.2% | Form 4 |
| Jan 21 – 22 | Matt Zuga CFO & Chief Business Officer | Sold10b5-1 plan 2 parts | 4,160 | $1.83 average | 8K | 1.3% | Form 4 |
| Jan 21 – 22 | Daniel Joseph Oconnell Chief Executive Officer | Sold10b5-1 plan 2 parts | 12,035 | $1.83 average | 22K | 1.3% | Form 4 |
| Jan 21 – 22 | Russell Barton Chief Operating Officer | Sold10b5-1 plan 2 parts | 2,777 | $1.81 average | 5K | 1.3% | Form 4 |
| Jan 8 – 12 | Derek M Meisner Chief Legal Officer & Corp Sec | Sold10b5-1 plan 4 parts | 50,659 | $1.80 average | 91K | 38% | Form 4 |
| Jan 8 – 12 | Daniel Joseph Oconnell Chief Executive Officer | Sold10b5-1 plan 3 parts | 26,472 | $1.77 average | 47K | 4.3% | Form 4 |
| Jan 8 | Matt Zuga CFO & Chief Business Officer | Sold10b5-1 plan | 6,888 | $1.82 | 13K | 3.2% | Form 4 |
| Jan 8 | Russell Barton Chief Operating Officer | Sold10b5-1 plan | 3,530 | $1.86 | 7K | 2.8% | Form 4 |
| Jan 7 – 8 | James J. Doherty President and CDO | Sold10b5-1 plan 2 parts | 8,167 | $1.86 average | 15K | 13% | Form 4 |
| Jan 7 | Amy Schacterle Chief Regulatory Officer | Sold10b5-1 plan | 1,097 | $1.98 | 2K | 12% | Form 4 |
| Jan 5 – 7 | Matt Zuga CFO & Chief Business Officer | Sold10b5-1 plan 4 parts | 14,905 | $1.98 average | 29K | 6.4% | Form 4 |
| Jan 5 – 7 | Daniel Joseph Oconnell Chief Executive Officer | Sold10b5-1 plan 3 parts | 47,506 | $1.99 average | 94K | 7.1% | Form 4 |
| Jan 5 – 7 | Derek M Meisner Chief Legal Officer & Corp Sec | Sold10b5-1 plan 5 parts | 26,668 | $1.98 average | 53K | 17% | Form 4 |
| Jan 5 – 7 | Russell Barton Chief Operating Officer | Sold10b5-1 plan 3 parts | 9,318 | $1.97 average | 18K | 6.8% | Form 4 |
| Jan 5 – 6 | Eric Siemers Chief Medical Officer | Sold10b5-1 plan 2 parts | 10,834 | $1.97 average | 21K | 6.4% | Form 4 |
| Jan 21, 2025 – Jan 23, 2025 | Matt Zuga CFO & Chief Business Officer | Sold10b5-1 plan 2 parts | 33,266 | $1.70 average | 57K | 13% | Form 4 |
| Jan 21, 2025 | Daniel Joseph Oconnell Chief Executive Officer | Sold10b5-1 plan | 12,619 | $1.59 | 20K | 1.9% | Form 4 |
| Jan 21, 2025 | Derek M Meisner Chief Legal Officer & Corp Sec | Sold10b5-1 plan | 3,418 | $1.59 | 5K | 2.1% | Form 4 |
| Jan 21, 2025 | Russell Barton Chief Operating Officer | Sold10b5-1 plan | 2,914 | $1.61 | 5K | 2.1% | Form 4 |
| Jan 21, 2025 | Eric Siemers Chief Medical Officer | Sold10b5-1 plan | 3,219 | $1.59 | 5K | 1.9% | Form 4 |
| Jan 3, 2025 | Daniel Joseph Oconnell Chief Executive Officer | Sold10b5-1 plan | 47,778 | $1.84 | 88K | 6.6% | Form 4 |
| Jan 3, 2025 | Derek M Meisner Chief Legal Officer & Corp Sec | Sold10b5-1 plan | 11,122 | $1.84 | 20K | 6.3% | Form 4 |
| Jan 3, 2025 | Russell Barton Chief Operating Officer | Sold10b5-1 plan | 7,636 | $1.86 | 14K | 5.2% | Form 4 |
| Jan 3, 2025 | Matt Zuga CFO & Chief Business Officer | Sold10b5-1 plan | 13,235 | $1.84 | 24K | 4.8% | Form 4 |
| Jan 3, 2025 | Eric Siemers Chief Medical Officer | Sold10b5-1 plan | 10,859 | $1.85 | 20K | 5.9% | Form 4 |
- Jun 15 – 17No planDerrell PorterDirector · sold 32,300 at avg $2.3375K48% of stake
- Jun 9No planNathan B FountainDirector · sold 6,400 at $2.2314K12% of stake
- Mar 610b5-1 planDerek M MeisnerChief Legal Officer & Corp Sec · sold 2,090 at $3.267K1.2% of stake
- Feb 2710b5-1 planDerek M MeisnerChief Legal Officer & Corp Sec · sold 9,406 at $3.0128K5.1% of stake
- Jan 26 – 2810b5-1 planDerek M MeisnerChief Legal Officer & Corp Sec · sold 17,756 at avg $3.0053K9.3% of stake
- Jan 21 – 2310b5-1 planDerek M MeisnerChief Legal Officer & Corp Sec · sold 8,934 at avg $1.8717K4.9% of stake
- Jan 21 – 2210b5-1 planEric SiemersChief Medical Officer · sold 3,226 at avg $1.816K1.2% of stake
- Jan 21 – 2210b5-1 planMatt ZugaCFO & Chief Business Officer · sold 4,160 at avg $1.838K1.3% of stake
- Jan 21 – 2210b5-1 planDaniel Joseph OconnellChief Executive Officer · sold 12,035 at avg $1.8322K1.3% of stake
- Jan 21 – 2210b5-1 planRussell BartonChief Operating Officer · sold 2,777 at avg $1.815K1.3% of stake
- Jan 8 – 1210b5-1 planDerek M MeisnerChief Legal Officer & Corp Sec · sold 50,659 at avg $1.8091K38% of stake
- Jan 8 – 1210b5-1 planDaniel Joseph OconnellChief Executive Officer · sold 26,472 at avg $1.7747K4.3% of stake
- Jan 810b5-1 planMatt ZugaCFO & Chief Business Officer · sold 6,888 at $1.8213K3.2% of stake
- Jan 810b5-1 planRussell BartonChief Operating Officer · sold 3,530 at $1.867K2.8% of stake
- Jan 7 – 810b5-1 planJames J. DohertyPresident and CDO · sold 8,167 at avg $1.8615K13% of stake
- Jan 710b5-1 planAmy SchacterleChief Regulatory Officer · sold 1,097 at $1.982K12% of stake
- Jan 5 – 710b5-1 planMatt ZugaCFO & Chief Business Officer · sold 14,905 at avg $1.9829K6.4% of stake
- Jan 5 – 710b5-1 planDaniel Joseph OconnellChief Executive Officer · sold 47,506 at avg $1.9994K7.1% of stake
- Jan 5 – 710b5-1 planDerek M MeisnerChief Legal Officer & Corp Sec · sold 26,668 at avg $1.9853K17% of stake
- Jan 5 – 710b5-1 planRussell BartonChief Operating Officer · sold 9,318 at avg $1.9718K6.8% of stake
- Jan 5 – 610b5-1 planEric SiemersChief Medical Officer · sold 10,834 at avg $1.9721K6.4% of stake
- Jan 21, 2025 – Jan 23, 202510b5-1 planMatt ZugaCFO & Chief Business Officer · sold 33,266 at avg $1.7057K13% of stake
- Jan 21, 202510b5-1 planDaniel Joseph OconnellChief Executive Officer · sold 12,619 at $1.5920K1.9% of stake
- Jan 21, 202510b5-1 planDerek M MeisnerChief Legal Officer & Corp Sec · sold 3,418 at $1.595K2.1% of stake
- Jan 21, 202510b5-1 planRussell BartonChief Operating Officer · sold 2,914 at $1.615K2.1% of stake
- Jan 21, 202510b5-1 planEric SiemersChief Medical Officer · sold 3,219 at $1.595K1.9% of stake
- Jan 3, 202510b5-1 planDaniel Joseph OconnellChief Executive Officer · sold 47,778 at $1.8488K6.6% of stake
- Jan 3, 202510b5-1 planDerek M MeisnerChief Legal Officer & Corp Sec · sold 11,122 at $1.8420K6.3% of stake
- Jan 3, 202510b5-1 planRussell BartonChief Operating Officer · sold 7,636 at $1.8614K5.2% of stake
- Jan 3, 202510b5-1 planMatt ZugaCFO & Chief Business Officer · sold 13,235 at $1.8424K4.8% of stake
- Jan 3, 202510b5-1 planEric SiemersChief Medical Officer · sold 10,859 at $1.8520K5.9% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Biological Products, (No Diagnostic Substances) · Pick stocks to compare with ABOS
Held by ETFs
ABOS is in 2 US ETFs. The largest of them, with ABOS's weight in each:
Spot a number that looks wrong? Check it in ABOS's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing ABOS
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.